---
layout: post
title: "Consideration of Enforcement Policies for In Vitro Diagnostic Tests During a Section 564 Declared Emergency; Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-04 21:49:24 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-18402
original_published: 2025-09-23 00:00:00 +0000
significance: 8.00
---

# Consideration of Enforcement Policies for In Vitro Diagnostic Tests During a Section 564 Declared Emergency; Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** September 23, 2025 00:00 UTC
**Document Number:** 2025-18402

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Consideration of Enforcement Policies for In Vitro Diagnostic Tests During a Section 564 Declared Emergency." This guidance describes the factors FDA intends to assess in deciding whether to issue an enforcement policy regarding in vitro diagnostic test manufacturers' offering of certain unapproved in vitro diagnostic tests and unapproved uses of approved in vitro diagnostic tests during a declared emergency.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/09/23/2025-18402/consideration-of-enforcement-policies-for-in-vitro-diagnostic-tests-during-a-section-564-declared)
- API: https://www.federalregister.gov/api/v1/documents/2025-18402

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
